Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Mar 24:376:e070650.
doi: 10.1136/bmj-2022-070650.

It is not too late to achieve global covid-19 vaccine equity

Gavin Yamey  1 , Patricia Garcia  2 , Fatima Hassan  3 , Wenhui Mao  4 , Kaci Kennedy McDade  4 , Madhukar Pai  5 , Senjuti Saha  6 , Philip Schellekens  7 , Andrea Taylor  8 , Krishna Udayakumar  8
Affiliations

It is not too late to achieve global covid-19 vaccine equity

Gavin Yamey et al. BMJ. .

Erratum in

Abstract

Gavin Yamey and colleagues say that a new, urgent push for global vaccine equity could help avert suffering and deaths, protect economies, and prevent new virus variants

PubMed Disclaimer

Conflict of interest statement

Competing interests: GY was a member of the covid-19 vaccine development taskforce hosted by the World Bank, and participated as an unpaid academic adviser in the consultation process that led to the launch of Covax. He has received grant funding from WHO; Gavi, the Vaccine Alliance; and the Bill and Melinda Gates Foundation. He is a funding member of Amnesty International, which is one of the members of the People’s Vaccine Alliance. PG participated as a member of the Data Safety and Monitoring Board for a phase 3 double blind, randomised, placebo controlled clinical trial for the evaluation of efficacy and safety in health professionals of the adsorbed vaccine covid-19 (inactivated) produced by Sinovac (study implemented by BUTANTAN in Brazil). FH is a member of the People’s Vaccine Alliance and serves on the advisory group of Resolve to SAVE Lives. WM has received research funding from WHO and the Bill and Melinda Gates Foundation. KKM was a member of the covid-19 vaccine development taskforce hosted by the World Bank and has received funding from WHO and the Bill and Melinda Gates Foundation. MP is an adviser to non-profit organisations such as the Bill and Melinda Gates Foundation, WHO, Stop TB Partnership, and Foundation for Innovative New Diagnostics; he has no financial or industry disclosures. SS has no competing interests. PS has contributed to this article in a personal capacity unconnected to his duties as an employee of the World Bank Group and has provided analytical and other inputs based on the data analytics resource pandem-ic.com that he also developed in a personal capacity. AT has received research funding through Duke University and Duke affiliated non-profit Innovations in Healthcare from Bill and Melinda Gates Foundation, The Rockefeller Foundation, USAID, Grand Challenges Canada, and Pfizer Foundation. KU has received research funding through Duke University and Duke affiliated non-profit Innovations in Healthcare from Bill and Melinda Gates Foundation, The Rockefeller Foundation, USAID, Grand Challenges Canada, Amgen, AstraZeneca, Bayer, Johnson and Johnson Foundation, Medtronic, Pfizer, Pfizer Foundation, Takeda, and Vynamic. He has served as unpaid adviser for the Hewlett Foundation and Africa CDC, and has received an honorarium from Weber Shandwick.

Figures

Fig 1
Fig 1
Booster coverage of total population, by income. Country observations (centre points) of boosters per 100 people by income group and total population size (area) with group averages (lines). HIC=high income countries; UMIC=upper middle income countries; LMIC=lower middle income countries; LIC=low income countries. Source: https://pandem-ic.com/booster-coverage-of-population-by-country-income-and-population-size/
Fig 2
Fig 2
Cumulative estimated excess deaths since the start of the pandemic per 100 000 people. HIC=high income countries; UMIC=upper middle income countries; LMIC=lower middle income countries; LIC=low income countries. Mid-point estimates of excess death model by The Economist. Source: https://pandem-ic.com/cumulative-estimated-excess-deaths-per-capita-by-income/
Fig 3
Fig 3
Ratio of the peak in cases and mortality rates for the current omicron/delta surge versus previous waves prior to 1 November 2021. Peaks calculated for daily weekly trailing averages of newly confirmed cases and deaths per 100 000 people. HIC=high income countries; UMIC=upper middle income countries; LMIC=lower middle income countries; LIC=low income countries. Source: https://pandem-ic.com/the-scale-of-the-omicron-escalation/
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Glassman A, Kenny C, Yang G. Covid-19 vaccine development and rollout in historical perspective. Center for Global Development. Feb 2022. Report no 607. https://www.cgdev.org/publication/covid-19-vaccine-development-and-rollo...
    1. Byanyima W. A global vaccine apartheid is unfolding. People’s lives must come before profit. Guardian 2021 Jan 29. https://www.theguardian.com/global-development/2021/jan/29/a-global-vacc...
    1. Sheel M, McEwen S, Davies SE. Brand inequity in access to COVID-19 vaccines. Lancet Reg Health West Pac 2022;18:100366. 10.1016/j.lanwpc.2021.100366 - DOI - PMC - PubMed
    1. Ritchie H, Mathieu E, Rodés-Guirao L, et al. Coronavirus vaccinations (COVID-19). Our World in Data 2020. https://ourworldindata.org/covid-vaccinations
    1. Wouters OJ, Shadlen KC, Salcher-Konrad M, et al. Challenges in ensuring global access to COVID-19 vaccines: production, affordability, allocation, and deployment. Lancet 2021;397:1023-34. 10.1016/S0140-6736(21)00306-8 - DOI - PMC - PubMed

Substances